logo-loader

NovaBay Pharmaceuticals

Receive alerts
Market:
NYSEMKT
Market Cap:
$18.5 m
Price
0.66 USD
Change
1.44%
52 weeks high
4.04
52 weeks low
0.25

In brief

NovaBay Pharmaceuticals $NBY is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market.